Deal will help to support integrated health and care activities

Akcea’s Waylivra approved via ultra-orphan pathway

RECOVERY study will assess if drug can reduce risk of blood clots

BTK inhibitor approved based on results from two phase III trials

“Consider a new route”Neil Snowise, visiting senior lecturer at the Institute of Pharmaceutical Science at King’s College, London, […]

The surname of Alessandra Borsini was misspelt in the author list of this article by Joseph Firth and […]

FDA reputation takes another hit after scathing aducanumab advisory panel meeting bbulik Mon, 11/09/2020 – 10:50

After Pfizer’s vaccine data, analysts say COVID drug makers face questions about long-term sales prospects esagonowsky Mon, 11/09/2020 […]

Phase III study of vaccine candidate involved 43,538 participants

GlaxoSmithKline’s HIV PrEP challenge looms as ViiV’s long-acting drug tops Gilead’s Truvada in women aliu Mon, 11/09/2020 – […]